NVCI Faculty Published in Prominent Medical Journals

Several Nevada Cancer Institute faculty members have been published in some important medical journals. Wolfram Samlowski, M.D., head of the Section of Melanoma, Renal Cancer and Immunotherapy; Bryan Wong, M.D., Ph.D., assistant member, Department of Hematological Malignancies; and Nicholas Vogelzang, M.D., director and executive vice president for Academic Affairs, wrote an editorial which was published in the British Journal of Urology International. The editorial is titled, “Management of renal cancer in the tyrosine kinase inhibitor era: a view from 3 years on.”

The editorial pointed out that there has been a dramatic increase in the treatment options for patients with metastatic renal cancer. In addition to the cytokines interferon and interleukin 2, recently approved agents include sorafenib, sunitinib, temsirolimus and bevacizumab. A large number of agents that are likely to have clinical activity are currently in the development ‘pipeline’. The editorial was an overview of recent developments that identified advances likely to influence treatment decisions.

read more »